Bay Area Addiction Research & Treatment

Bay Area Addiction Research & Treatment (BAART Programs) provides specialized opioid addiction treatment through medication-assisted treatment and comprehensive counseling, focusing on individualized care to support long-term recovery. Founded in 1977 and headquartered in San Francisco, US, Bay Area Addiction Research & Treatment (BAART Programs) specializes in opioid addiction treatment. The company was acquired by Webster Capital in June 2015, with financial terms undisclosed. Evan Kletter serves as the CEO.

BAART Programs offers a range of opioid addiction treatment services, including medication-assisted treatment (MAT) and substance use counseling. MAT employs prescribed medications to help alleviate cravings and withdrawal symptoms, enhancing patient engagement in recovery. Their approach is personalized, addressing individual needs and incorporating additional support services such as case management and community resource referrals. BAART operates treatment centers across multiple states, notably in Arizona, California, Colorado, Kansas, Louisiana, Nebraska, North Carolina, South Dakota, Utah, Vermont, and Washington, ensuring access for underserved populations.

The company generates revenue through outpatient treatment services, which include interactions with clients seeking opioid addiction assistance. Many services, like medication and counseling, are often covered by insurance plans or available through private pay options, fostering supportive relationships as clients navigate recovery. As of the latest update in June 2015, following its acquisition by Webster Capital, BAART Programs plans to enhance its service offerings and expand into additional geographic markets. Future growth may involve launching new treatment programs tailored to specific regional needs.

Recent funding will support these initiatives, although specific details on financial allocations have not been disclosed.